Search Results - "Vadelová, Ľubica"

Assessing the hemostasis with thromboelastometry in direct oral anticoagulants-treated patients with atrial fibrillation by Korpallová, Barbora, Samoš, Matej, Škorňová, Ingrid, Bolek, Tomáš, Žolková, Jana, Vadelová, Ľubica, Kubisz, Peter, Galajda, Peter, Staško, Ján, Mokáň, Marián

“…•This study tested the ability of ROTEM® to identify changes in hemostasis in a real-world sample of DOACs-treated (dabigatran, rivaroxaban, and…”
Get full text

Does atorvastatin therapy change the anti‐Xa activity in xabans‐treated patients with atrial fibrillation? by Škorňová, Ingrid, Samoš, Matej, Bolek, Tomáš, Stančiaková, Lucia, Vádelová, Ľubica, Galajda, Peter, Staško, Ján, Kubisz, Peter, Mokáň, Marián

“…Atorvastatin and direct oral factor Xa inhibitors (xabans) are frequently co‐administrated in patients with atrial fibrillation (AF). However, no studies…”
Get full text

Heparin induced thrombocytopenia and up to date options of treatment - review of literature by Sokol, Juraj, Nehaj, František, Chudej, Juraj, Mokáň, Michal, Kubašková, Marianna, Péč, Martin Jozef, Žolková, Jana, Vadelová, Ubica, Galajda, Peter, Staško, Ján

“…Heparin-induced thrombocytopenia (HIT) is a profoundly dangerous, potentially lethal, immunologically mediated adverse drug reaction to unfractionated heparin…”
Get more information

How can Secondary Thromboprophylaxis in High-Risk Pregnant Patients be Improved? by Stanciakova, Lucia, Dobrotova, Miroslava, Holly, Pavol, Zolkova, Jana, Vadelova, Lubica, Skornova, Ingrid, Ivankova, Jela, Samos, Matej, Bolek, Tomas, Grendar, Marian, Danko, Jan, Kubisz, Peter, Stasko, Jan

“…Low-molecular-weight heparin (LMWH) is suggested for thromboprophylaxis in pregnant women with previous venous thromboembolism (VTE). Anyway, there is only…”
Get full text

Impact of Edoxaban on Thrombin-Dependent Platelet Aggregation by Sokol, Juraj, Nehaj, Frantisek, Ivankova, Jela, Mokan, Michal, Lisa, Lenka, Zolkova, Jana, Vadelova, Lubica, Mokan, Marian, Stasko, Jan

“…Edoxaban, a direct factor Xa inhibitor (FXa), is the fourth direct oral anticoagulant (DOAC) approved for clinical use. As the main adverse event is bleeding,…”
Get full text

Platelet miRNA Expression in Patients with Sticky Platelet Syndrome by Belakova, Kristina Maria, Zolkova, Jana, Vadelova, Lubica, Skerenova, Maria, Ivankova, Jela, Lenka, Lisa, Sokol, Juraj, Stasko, Jan

“…Sticky platelet syndrome (SPS) is a disorder with familial occurrence and autosomal dominant trait characterized by platelet hyperaggregability in response to…”
Get full text

DNA Polymorphisms in Pregnant Women with Sticky Platelet Syndrome by Stančiaková, Lucia, Žolková, Jana, Vadelová, Ľubica, Hornáková, Andrea, Kolková, Zuzana, Vážan, Martin, Dobrotová, Miroslava, Hollý, Pavol, Jedináková, Zuzana, Grendár, Marián, Bolek, Tomáš, Samoš, Matej, Biringer, Kamil, Danko, Ján, Burjanivová, Tatiana, Lasabová, Zora, Kubisz, Peter, Staško, Ján

“…Sticky platelet syndrome (SPS) is a thrombophilia caused by the increased aggregability of platelets in response to the addition of low concentrations of…”
Get full text

How Can Rotational Thromboelastometry as a Point-of-Care Method Be Useful for the Management of Secondary Thromboprophylaxis in High-Risk Pregnant Patients? by Stanciakova, Lucia, Dobrotova, Miroslava, Holly, Pavol, Zolkova, Jana, Vadelova, Lubica, Skornova, Ingrid, Ivankova, Jela, Bolek, Tomas, Samos, Matej, Grendar, Marian, Danko, Jan, Kubisz, Peter, Stasko, Jan

“…Thromboprophylaxis with low-molecular-weight heparin (LMWH) for patients with a history of venous thromboembolism (VTE) is suggested. Rotational…”
Get full text